View in EDS

Phase III trial of gemcitabine plus docetaxel versus capecitabine plus docetaxel with planned crossover to the alternate single agent in metastatic breast cancer.

Saved in:
Bibliographic Details
Title: Phase III trial of gemcitabine plus docetaxel versus capecitabine plus docetaxel with planned crossover to the alternate single agent in metastatic breast cancer.
Authors: Seidman AD; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York. Electronic address: seidmana@mskcc.org., Brufsky A; Women's Cancer Center, Magee Women's Hospital, Pittsburgh., Ansari RH; Michiana Hematology Oncology, South Bend., Hart LL; Florida Cancer Specialists, Venice., Stein RS; Department of Molecular Physiology and Biophysics, Vanderbilt-Ingram Cancer Center, Nashville., Schwartzberg LS; Hematology and Medical Oncology, The West Clinic, Memphis, USA., Stewart JF; Calvary Mater Hospital, Waratah, Australia., Russell CA; Department of Clinical Medicine, University of Southern California, Los Angeles, USA., Chen SC; Department of Surgery, Chang Gung Memorial Hospital, Taipei, Taiwan., Fein LE; Centro de Oncologia Rosario, Santa Fe, Argentina., De La Cruz Vargas JA; Department of Oncology and Clinical Research, Acapulco Oncology Group, Acapulco, Mexico., Kim SB; Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea., Cavalheiro J; Hospital de Clinicas, Porto Alegre, Brazil., Zhao L; Lilly USA, LLC, Indianapolis., Gill JF; Lilly USA, LLC, Indianapolis., Obasaju CK; Lilly USA, LLC, Indianapolis., Orlando M; Eli Lilly and Company, Indianapolis, USA., Tai DF; Lilly USA, LLC, Indianapolis.
Source: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2011 May; Vol. 22 (5), pp. 1094-1101. Date of Electronic Publication: 2010 Nov 17.
Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 21084429
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Phase III trial of gemcitabine plus docetaxel versus capecitabine plus docetaxel with planned crossover to the alternate single agent in metastatic breast cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Seidman+AD%22">Seidman AD</searchLink>; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York. Electronic address: seidmana@mskcc.org.<br /><searchLink fieldCode="AU" term="%22Brufsky+A%22">Brufsky A</searchLink>; Women's Cancer Center, Magee Women's Hospital, Pittsburgh.<br /><searchLink fieldCode="AU" term="%22Ansari+RH%22">Ansari RH</searchLink>; Michiana Hematology Oncology, South Bend.<br /><searchLink fieldCode="AU" term="%22Hart+LL%22">Hart LL</searchLink>; Florida Cancer Specialists, Venice.<br /><searchLink fieldCode="AU" term="%22Stein+RS%22">Stein RS</searchLink>; Department of Molecular Physiology and Biophysics, Vanderbilt-Ingram Cancer Center, Nashville.<br /><searchLink fieldCode="AU" term="%22Schwartzberg+LS%22">Schwartzberg LS</searchLink>; Hematology and Medical Oncology, The West Clinic, Memphis, USA.<br /><searchLink fieldCode="AU" term="%22Stewart+JF%22">Stewart JF</searchLink>; Calvary Mater Hospital, Waratah, Australia.<br /><searchLink fieldCode="AU" term="%22Russell+CA%22">Russell CA</searchLink>; Department of Clinical Medicine, University of Southern California, Los Angeles, USA.<br /><searchLink fieldCode="AU" term="%22Chen+SC%22">Chen SC</searchLink>; Department of Surgery, Chang Gung Memorial Hospital, Taipei, Taiwan.<br /><searchLink fieldCode="AU" term="%22Fein+LE%22">Fein LE</searchLink>; Centro de Oncologia Rosario, Santa Fe, Argentina.<br /><searchLink fieldCode="AU" term="%22De+La+Cruz+Vargas+JA%22">De La Cruz Vargas JA</searchLink>; Department of Oncology and Clinical Research, Acapulco Oncology Group, Acapulco, Mexico.<br /><searchLink fieldCode="AU" term="%22Kim+SB%22">Kim SB</searchLink>; Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.<br /><searchLink fieldCode="AU" term="%22Cavalheiro+J%22">Cavalheiro J</searchLink>; Hospital de Clinicas, Porto Alegre, Brazil.<br /><searchLink fieldCode="AU" term="%22Zhao+L%22">Zhao L</searchLink>; Lilly USA, LLC, Indianapolis.<br /><searchLink fieldCode="AU" term="%22Gill+JF%22">Gill JF</searchLink>; Lilly USA, LLC, Indianapolis.<br /><searchLink fieldCode="AU" term="%22Obasaju+CK%22">Obasaju CK</searchLink>; Lilly USA, LLC, Indianapolis.<br /><searchLink fieldCode="AU" term="%22Orlando+M%22">Orlando M</searchLink>; Eli Lilly and Company, Indianapolis, USA.<br /><searchLink fieldCode="AU" term="%22Tai+DF%22">Tai DF</searchLink>; Lilly USA, LLC, Indianapolis.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229007735%22">Annals of oncology : official journal of the European Society for Medical Oncology</searchLink> [Ann Oncol] 2011 May; Vol. 22 (5), pp. 1094-1101. <i>Date of Electronic Publication: </i>2010 Nov 17.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9007735 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1569-8041 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209237534%22">09237534 </searchLink><i>NLM ISO Abbreviation: </i>Ann Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=21084429
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1093/annonc/mdq578
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1094
    Titles:
      – TitleFull: Phase III trial of gemcitabine plus docetaxel versus capecitabine plus docetaxel with planned crossover to the alternate single agent in metastatic breast cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Seidman AD
      – PersonEntity:
          Name:
            NameFull: Brufsky A
      – PersonEntity:
          Name:
            NameFull: Ansari RH
      – PersonEntity:
          Name:
            NameFull: Hart LL
      – PersonEntity:
          Name:
            NameFull: Stein RS
      – PersonEntity:
          Name:
            NameFull: Schwartzberg LS
      – PersonEntity:
          Name:
            NameFull: Stewart JF
      – PersonEntity:
          Name:
            NameFull: Russell CA
      – PersonEntity:
          Name:
            NameFull: Chen SC
      – PersonEntity:
          Name:
            NameFull: Fein LE
      – PersonEntity:
          Name:
            NameFull: De La Cruz Vargas JA
      – PersonEntity:
          Name:
            NameFull: Kim SB
      – PersonEntity:
          Name:
            NameFull: Cavalheiro J
      – PersonEntity:
          Name:
            NameFull: Zhao L
      – PersonEntity:
          Name:
            NameFull: Gill JF
      – PersonEntity:
          Name:
            NameFull: Obasaju CK
      – PersonEntity:
          Name:
            NameFull: Orlando M
      – PersonEntity:
          Name:
            NameFull: Tai DF
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 05
              Text: 2011 May
              Type: published
              Y: 2011
          Identifiers:
            – Type: issn-electronic
              Value: 1569-8041
          Numbering:
            – Type: volume
              Value: 22
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: Annals of oncology : official journal of the European Society for Medical Oncology
              Type: main
ResultId 1